University of Turku
🇧🇪Belgium
- Country
- 🇧🇪Belgium
- Ownership
- Private
- Established
- 1920-01-01
- Employees
- 3.2K
- Market Cap
- -
- Website
- http://www.utu.fi
LGG/BB12-pastille Study
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2012-04-13
- Last Posted Date
- 2013-01-04
- Lead Sponsor
- University of Turku
- Target Recruit Count
- 60
- Registration Number
- NCT01577485
- Locations
- 🇫🇮
Institute of Dentistry, Turku, Finland
Competition With Striatal [11C]ORM-13070 Binding by Atipamezole and Endogenous Noradrenaline
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-09-16
- Last Posted Date
- 2013-02-18
- Lead Sponsor
- University of Turku
- Target Recruit Count
- 10
- Registration Number
- NCT01435213
- Locations
- 🇫🇮
University of Turku, Clinical Research Services Turku CRST, Turku, Finland
🇫🇮University of Turku, Turku PET Centre, Turku, Finland
Colecalciferol as an Add-on Treatment to Subcutaneously-Administered Interferon-beta-1b for Treatment of Multiple Sclerosis (MS)
- First Posted Date
- 2011-09-13
- Last Posted Date
- 2011-09-13
- Lead Sponsor
- University of Turku
- Target Recruit Count
- 70
- Registration Number
- NCT01432704
Does Administration of Probiotics During Infancy Increase the Caries Risk of a Child
Not Applicable
Withdrawn
- Conditions
- Interventions
- First Posted Date
- 2011-08-29
- Last Posted Date
- 2012-02-22
- Lead Sponsor
- University of Turku
- Registration Number
- NCT01424852
- Locations
- 🇫🇮
University of Turku, Turku, Finland
Vascular Healing of DES at 3 Months
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-07-12
- Last Posted Date
- 2013-08-02
- Lead Sponsor
- University of Turku
- Target Recruit Count
- 46
- Registration Number
- NCT01391871
- Locations
- 🇫🇮
Satakunta Central Hospital, Pori, Pori, Finland
🇫🇮Turku University Hospital, Turku, Finland
Colecalciferol as an Add-on Treatment to Interferon-beta-1b for Treatment of Multiple Sclerosis (MS)
- First Posted Date
- 2011-04-21
- Last Posted Date
- 2011-05-19
- Lead Sponsor
- University of Turku
- Target Recruit Count
- 70
- Registration Number
- NCT01339676
- Locations
- 🇫🇮
Turku University Hospital, Turku, Finland
Study of Usefulness of Genotyping to Predict Docetaxel Exposure and Adverse Events
- First Posted Date
- 2010-04-26
- Last Posted Date
- 2010-04-27
- Lead Sponsor
- University of Turku
- Target Recruit Count
- 20
- Registration Number
- NCT01110291
- Locations
- 🇫🇮
Turku University Hospital, Turku, Finland
Effect of Dexmedetomidine on Gastric Emptying and Gastrointestinal Transit
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2010-03-10
- Last Posted Date
- 2010-06-04
- Lead Sponsor
- University of Turku
- Target Recruit Count
- 12
- Registration Number
- NCT01084473
- Locations
- 🇫🇮
Department of Anaesthesiology, Intensive Care, Emergency Care and Pain Medicine, Turku University and Turku University Hospital, Turku, Finland
Bioavailability of Dexmedetomidine After Intranasal Administration
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-02-05
- Last Posted Date
- 2010-01-13
- Lead Sponsor
- University of Turku
- Target Recruit Count
- 7
- Registration Number
- NCT00837187
- Locations
- 🇫🇮
Turku University Hospital, Turku, Finland
Non-small Cell Lung Cancer and Quality of Life
Completed
- Conditions
- First Posted Date
- 2009-01-07
- Last Posted Date
- 2015-05-29
- Lead Sponsor
- University of Turku
- Target Recruit Count
- 130
- Registration Number
- NCT00818402
© Copyright 2024. All Rights Reserved by MedPath